Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Calhoun DH, Coppola G. Recombinant alpha-galactosidase A therapy for Fabry disease. US Patent 5,179,023 dated Jan 12 1993
